Microdosing Mushrooms: A Guide To The Sensations And Effects

Microdosing is the practice of taking a fraction of the standard recreational or clinical dose of a psychedelic substance. The popularity of microdosing has led to renewed interest in researching the potential benefits of psychedelic drugs. While some people report positive effects such as improved mood, creativity, and concentration, others have reported negative effects such as insomnia, increased anxiety, and poor mood. The existing research on the effects of microdosing is mixed, and the lack of standardised definitions and regulations for microdosing makes consistent research challenging. This article will explore the subjective experiences and current scientific understanding of microdosing mushrooms.

Microdosing mushrooms may improve mental health

Microdosing is typically defined by experts as taking 5% to 10% of a full dose of a psychedelic, usually LSD or psilocybin, to get the supposed mental health benefits of the drug without the hallucinogenic high. Microdosing mushrooms may improve mental health, but there is little empirical research to support this claim. However, some people have reported improvements in their mental well-being after microdosing.

Some mothers in Colorado, for example, have begun a regimen of microdosing psychedelics to ease the mounting stress and anxiety of being a busy mother. One mother, Tracey Tee, who runs an online and in-person community called Moms On Mushrooms, said that microdosing helped her slowly stop taking antidepressants and anti-anxiety medicines. She also said that microdosing helped her face her emotions and let them go. Another mother, Heather Jackson, CEO of Unlimited Sciences, a psychedelic research company, takes microdoses of psilocybin to manage her stress.

Some people who microdose report feeling happier and more creative, with improved mood, morale, and energy. One person described it as akin to "walking outside and the sun is suddenly out". However, it is hard to be sure that the psilocybin microdoses' pharmacological properties are solely or significantly responsible for the reported improvements in mental health. The placebo effect may also play a role, as people who take psychedelics often have positive expectations of the outcomes.

Some studies have found that people who thought they had taken psychedelics felt greater well-being and lower anxiety than those who thought they had taken a placebo. However, one randomized controlled study found that while there were some intriguing subjective effects (people felt happier and more creative), there was no objective evidence of improvements in creativity, well-being, and cognitive function.

It could be a placebo effect

Microdosing with psychedelics like psilocybin mushrooms is a growing practice among recreational users. Many people share the idea that it enhances their mood, creativity, concentration, productivity, and ability to empathize with others. However, the evidence from recent studies is mixed, and it is challenging to perform consistent research due to the lack of a clear definition of microdosing for psychedelic drugs.

While some people report positive experiences, it is hard to determine if the benefits are solely due to the pharmacological properties of psilocybin microdoses. The placebo effect, or expectancy effect, may play a significant role in the perceived improvements. In a randomized controlled study, participants who received psilocybin and those who received a placebo reported feeling happier and more creative, but there was no objective evidence of improved creativity, well-being, or cognitive function in the psilocybin group.

Another self-blinding study found that people who thought they had taken psychedelics reported greater well-being and lower anxiety than those who thought they had taken a placebo. However, participants sometimes guessed correctly whether they had received the active substance or the placebo, which may have influenced the results.

The expectancy effect is a significant consideration in psychedelic research. Many people who start microdosing have preconceived positive expectations, influenced by word of mouth or online hype. This expectancy may contribute to the perceived benefits, as individuals may feel happier and smarter simply from taking a pill, regardless of its actual contents.

Additionally, extra-pharmacological factors such as positive expectations and a calming environment may also be responsible for the observed improvements in mental health. For example, individuals who engage in self-isolation and meditation in stress-free natural settings have reported meaningful experiences without the use of psychedelics. Therefore, while microdosing mushrooms may provide benefits, it is important to consider the potential influence of the placebo effect and manage expectations accordingly.

There is limited research

Microdosing is the practice of taking a fraction of a regular dose of a drug, typically defined as 5% to 10% of a full dose of a psychedelic. While microdosing has become a growing trend among recreational users, there is limited empirical research supporting the claimed benefits.

A study by Johns Hopkins University psychedelics researcher Albert Garcia-Romeu found that people who thought they had taken psychedelics reported greater well-being and lower anxiety than those who thought they had taken a placebo. However, the study had some limitations, as participants were free to set their own microdose regimens, and the doses and substances varied.

Another randomized controlled study found that while there were some intriguing subjective effects, such as people feeling happier and more creative, and even some changes in brain waves, there was no objective evidence of improvements in creativity, well-being, and cognitive function from low-dose psilocybin mushrooms.

The limited research in this area is partly due to the War on Drugs, which curtailed much of the research into psychedelics starting in the late 1960s. While research has been renewed in recent years, the lack of a clearly recognized definition of microdosing for psychedelic drugs complicates attempts to perform consistent research.

Despite the limited research, some individuals have reported positive experiences with microdosing mushrooms, claiming improvements in mental health, mood, and energy levels. However, it is important to note that the effects of microdosing can vary depending on factors such as personality, mood, expectations, surroundings, health, and previous substance use.

It may have adverse effects

Microdosing mushrooms is a growing practice among recreational users, with many people believing that it improves their mental health and cognitive abilities. However, it is important to note that there is limited empirical research to support these claims, and the potential adverse effects of this practice should not be overlooked.

Firstly, microdosing mushrooms can lead to insomnia, increased anxiety and depression, poor mood, low energy, and physical discomfort. The physical discomforts may include gastrointestinal symptoms, headaches, disrupted senses, and temperature dysfunction. Additionally, some individuals have reported experiencing poor focus and cognitive functioning, as well as impaired concentration and productivity, which contradicts the belief that microdosing enhances concentration and productivity.

Secondly, the experience of microdosing mushrooms can be unpredictable and may vary depending on factors such as the individual's personality, mood, expectations, surroundings, health, type of mushroom, previous experience with similar substances, and combined use with other drugs. This unpredictability increases the risk of adverse effects, as some people have reported unpleasant experiences or ""bad trips," involving extreme fear, confusion, or panic.

Furthermore, the potency of mushrooms can vary greatly, as they are not regulated outside of clinical trials, making it difficult to determine the appropriate dosage for microdosing. Taking too large of a dose can result in a terrifying or even traumatic experience, and the potential long-term effects of regular microdosing are not yet fully understood.

While some people have reported positive effects from microdosing mushrooms, it is important to approach this practice with caution. The potential adverse effects highlight the need for more comprehensive research and understanding before widely recommending or legalizing the use of microdosing mushrooms for therapeutic purposes.

It may improve mood, creativity and empathy

Microdosing with psilocybin mushrooms, or "magic mushrooms", is a growing practice among recreational users. It involves taking a fraction of a regular dose, or approximately 1/5 to 1/20 of a recreational dose. Many people believe that microdosing can enhance their mood, creativity, concentration, productivity, and ability to empathize with others.

Some people who microdose mushrooms report feeling happier, more positive, and having more "pep in their step". One person described the experience as "akin to walking outside and the sun is suddenly out". Another person reported feeling more connected to their work and peers, and feeling less negative.

There is some evidence to suggest that microdosing mushrooms can improve mood, creativity, and empathy. In one randomized controlled study, participants who took psilocybin mushrooms reported feeling happier and more creative. They also exhibited some changes in brain waves recorded on an EEG machine. However, the same study concluded that low-dose psilocybin mushrooms did not show objective evidence of improvements in creativity, well-being, and cognitive function.

It is important to note that there is a lack of consistent research on the effects of microdosing mushrooms due to the varying definitions of a microdose and the potency of mushrooms. Additionally, some researchers argue that the benefits of microdosing may be due to an expectancy effect, where individuals expect to feel happier and smarter after taking a pill, regardless of what is in it.

While some people have reported positive experiences with microdosing mushrooms, it is important to approach the practice with caution. Psilocybin can be safe in low doses, but it is important to obtain mushrooms from a trusted source as potency can vary. Furthermore, some individuals have reported unpleasant experiences or "bad trips" involving extreme fear, confusion, or panic. Adverse effects of psilocybin can include increased blood pressure and heart rate, headache, nausea, dizziness, fatigue, poor sleep, anxiety, paranoia, persistent psychosis, and hallucinations.

Frequently asked questions